398 related articles for article (PubMed ID: 19719543)
1. Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures.
Silberstein S; Lipton R; Dodick D; Freitag F; Mathew N; Brandes J; Bigal M; Ascher S; Morein J; Wright P; Greenberg S; Hulihan J
Headache; 2009 Sep; 49(8):1153-62. PubMed ID: 19719543
[TBL] [Abstract][Full Text] [Related]
2. Trial of Amitriptyline, Topiramate, and Placebo for Pediatric Migraine.
Powers SW; Coffey CS; Chamberlin LA; Ecklund DJ; Klingner EA; Yankey JW; Korbee LL; Porter LL; Hershey AD;
N Engl J Med; 2017 Jan; 376(2):115-124. PubMed ID: 27788026
[TBL] [Abstract][Full Text] [Related]
3. Topiramate for the prophylaxis of episodic migraine in adults.
Linde M; Mulleners WM; Chronicle EP; McCrory DC
Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD010610. PubMed ID: 23797676
[TBL] [Abstract][Full Text] [Related]
4. Aspirin with or without an antiemetic for acute migraine headaches in adults.
Kirthi V; Derry S; Moore RA; McQuay HJ
Cochrane Database Syst Rev; 2010 Apr; (4):CD008041. PubMed ID: 20393963
[TBL] [Abstract][Full Text] [Related]
5. Rapid resolution of migraine symptoms after initiating the preventive treatment eptinezumab during a migraine attack: results from the randomized RELIEF trial.
Ailani J; McAllister P; Winner PK; Chakhava G; Krog Josiassen M; Lindsten A; Sperling B; Ettrup A; Cady R
BMC Neurol; 2022 Jun; 22(1):205. PubMed ID: 35659622
[TBL] [Abstract][Full Text] [Related]
6. Impact of preventive pill-based treatment on migraine days: A secondary outcome study of the Childhood and Adolescent Migraine Prevention (CHAMP) trial and a comparison of self-report to nosology-derived assessments.
Gibler RC; Peugh JL; Coffey CS; Chamberlin LA; Ecklund D; Klingner E; Yankey J; Korbee LL; Kabbouche M; Kacperski J; Porter LL; Reidy BL; Hershey AD; Powers SW
Headache; 2023 Jun; 63(6):805-812. PubMed ID: 36757131
[TBL] [Abstract][Full Text] [Related]
7. Systematic review of outcomes and endpoints in acute migraine clinical trials.
Houts CR; McGinley JS; Nishida TK; Buse DC; Wirth RJ; Dodick DW; Goadsby PJ; Lipton RB
Headache; 2021 Feb; 61(2):263-275. PubMed ID: 33611818
[TBL] [Abstract][Full Text] [Related]
8. Clinical effectiveness of pharmacological interventions for managing chronic migraine in adults: a systematic review and network meta-analysis.
Naghdi S; Underwood M; Madan J; Brown A; Duncan C; Matharu M; Aksentyte A; Davies N; Rees S; Cooklin A; Grove A; Mistry H
J Headache Pain; 2023 Dec; 24(1):164. PubMed ID: 38057728
[TBL] [Abstract][Full Text] [Related]
9. Melatonin for migraine prevention in children and adolescents: A randomized, double-blind, placebo-controlled trial after single-blind placebo lead-in.
Gelfand AA; Allen IE; Grimes B; Irwin S; Qubty W; Greene K; Waung M; Powers SW; Szperka CL
Headache; 2023 Oct; 63(9):1314-1326. PubMed ID: 37466211
[TBL] [Abstract][Full Text] [Related]
10. European Headache Federation (EHF) critical reappraisal and meta-analysis of oral drugs in migraine prevention - part 3: topiramate.
Raffaelli B; García-Azorín D; Boucherie DM; Amin FM; Deligianni CI; Gil-Gouveia R; Kirsh S; Lampl C; Sacco S; Uluduz D; Versijpt J; MaassenVanDenBrink A; Zeraatkar D; Sanchez-Del-Rio M; Reuter U
J Headache Pain; 2023 Oct; 24(1):134. PubMed ID: 37814223
[TBL] [Abstract][Full Text] [Related]
11. Acute withdrawal and botulinum toxin A in chronic migraine with medication overuse: a double-blind randomized controlled trial.
Pijpers JA; Kies DA; Louter MA; van Zwet EW; Ferrari MD; Terwindt GM
Brain; 2019 May; 142(5):1203-1214. PubMed ID: 30982843
[TBL] [Abstract][Full Text] [Related]
12. A 12-week randomized double-blind clinical trial of eicosapentaenoic acid intervention in episodic migraine.
Wang HF; Liu WC; Zailani H; Yang CC; Chen TB; Chang CM; Tsai IJ; Yang CP; Su KP
Brain Behav Immun; 2024 May; 118():459-467. PubMed ID: 38499208
[TBL] [Abstract][Full Text] [Related]
13. Topiramate plus nortriptyline in the preventive treatment of migraine: a controlled study for nonresponders.
Krymchantowski AV; da Cunha Jevoux C; Bigal ME
J Headache Pain; 2012 Jan; 13(1):53-9. PubMed ID: 22008899
[TBL] [Abstract][Full Text] [Related]
14. Exercise as migraine prophylaxis: a randomized study using relaxation and topiramate as controls.
Varkey E; Cider A; Carlsson J; Linde M
Cephalalgia; 2011 Oct; 31(14):1428-38. PubMed ID: 21890526
[TBL] [Abstract][Full Text] [Related]
15. TOP-PRO study: A randomized double-blind controlled trial of topiramate versus propranolol for prevention of chronic migraine.
Chowdhury D; Bansal L; Duggal A; Datta D; Mundra A; Krishnan A; Koul A; Gupta A
Cephalalgia; 2022 Apr; 42(4-5):396-408. PubMed ID: 34579560
[TBL] [Abstract][Full Text] [Related]
16. Topiramate in migraine progression.
Ruiz L; Ferrandi D
J Headache Pain; 2009 Dec; 10(6):419-22. PubMed ID: 19838625
[TBL] [Abstract][Full Text] [Related]
17. Patient-identified most bothersome symptom in preventive migraine treatment with eptinezumab: A novel patient-centered outcome.
Lipton RB; Dodick DW; Ailani J; McGill L; Hirman J; Cady R
Headache; 2021 May; 61(5):766-776. PubMed ID: 34013992
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of eptinezumab in patients with chronic migraine and medication-overuse headache: a randomized, double-blind, placebo-controlled study.
Yu S; Zhou J; Luo G; Xiao Z; Ettrup A; Jansson G; Florea I; Ranc K; Pozo-Rosich P
BMC Neurol; 2023 Dec; 23(1):441. PubMed ID: 38102535
[TBL] [Abstract][Full Text] [Related]
19. Topiramate Monotherapy for Civilian Posttraumatic Stress Disorder: A Controlled Pilot Study.
Monga V; Petty F; Padala K; Padala PR
Prim Care Companion CNS Disord; 2023 Oct; 25(5):. PubMed ID: 37857291
[No Abstract] [Full Text] [Related]
20. Long-term effectiveness of eptinezumab in patients with migraine and prior preventive treatment failures: extension of a randomized controlled trial.
Ashina M; Tepper SJ; Gendolla A; Sperling B; Ettrup A; Josiassen MK; Starling AJ
J Headache Pain; 2023 Nov; 24(1):155. PubMed ID: 37985968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
